April 13, 2012 — The bladder holds a world of bacteria that do not show up in standard cultures, regardless of whether a woman has symptoms of a urinary tract infection, according to a study published ...

Early on-treatment (on-Rx) tumor volume reduction (TVR) to predict response to the KEYNOTE-522 (KN-522) regimen in early stage triple negative breast cancer (TNBC).

Quantitative PCR (qPCR) has become a cornerstone of molecular biology, offering precise DNA quantification in real time. Yet, challenges such as the need for high-quality nucleic acids, throughput ...

Adding carboplatin to standard neoadjuvant chemotherapy improves overall survival in TNBC, but the benefit is only ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced that ...